Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B5d2004fadc8f780ed5a22505156d91fb> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B5d2004fadc8f780ed5a22505156d91fb NCIT_P378 "NCI" @default.
- B5d2004fadc8f780ed5a22505156d91fb type Axiom @default.
- B5d2004fadc8f780ed5a22505156d91fb annotatedProperty IAO_0000115 @default.
- B5d2004fadc8f780ed5a22505156d91fb annotatedSource NCIT_C160108 @default.
- B5d2004fadc8f780ed5a22505156d91fb annotatedTarget "A regimen consisting of pembrolizumab that may be used in the treatment of anal, anaplastic, Merkel cell, and thymic carcinomas; appendiceal, pancreatic, and small bowel adenocarcinomas; alveolar soft part sarcoma; soft tissue sarcoma; bladder, breast, esophageal and esophagogastric junction, kidney, occult primary, gastric, bone, colorectal, cervical, non-small cell lung, small cell lung, penile, testicular, prostate, hepatobiliary, endometrial, and vulvar, and ovarian, fallopian tube and primary peritoneal cancers; head and neck cancer including cancer of the nasopharynx; gestational trophoblastic neoplasia; chronic lymphocytic leukemia (CLL); small lymphocytic lymphoma (SLL); diffuse large B-cell lymphoma (DLBCL); Hodgkin lymphoma; T-cell lymphomas; mycosis fungoides/Sezary syndrome; follicular, medullary, papillary and Hurthle cell thyroid carcinomas; malignant germ cell tumors; adrenal gland and neuroendocrine tumors (NETs); extrapulmonary poorly differentiated neuroendocrine carcinoma, large or small cell carcinoma, and mixed neuroendocrine-non-neuroendocrine neoplasm; squamous cell skin cancer; and cutaneous and uveal melanoma." @default.